Company page

Spruce Biosciences, Inc.

Spruce Biosciences, Inc. (Ticker: SPRB) is a public company based in the United States, focusing on developing innovative therapies for rare endocrine disorders. With a market capitalization of approximately $137.8 million, Spruce is dedicated to advancing its clinical programs and addressing unmet medical needs in the healthcare sector.